Test Price
2,800 AED✅ Home Collection Available
TFG Gene Hereditary Motor and Sensory Neuropathy, Okinawa Type Genetic Test in UAE | 2,800 AED | DHA Licensed Molecular Diagnostics
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection, Available Daily from 8 AM to 11 PM.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation with a DHA-licensed medical geneticist.
- Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The TFG Gene NGS Test is a definitive molecular diagnostic tool for Hereditary Motor and Sensory Neuropathy, Okinawa Type (HMSN‑P), a rare autosomal dominant peripheral neuropathy. In the UAE, this test leverages high‑throughput next‑generation sequencing to identify pathogenic variants in the TFG gene with unmatched accuracy, enabling early clinical intervention and informed family planning.
| Feature | Our Test (NGS‑TFG) | Closest Alternative (Sanger Sequencing Single Gene) |
|---|---|---|
| Methodology | High‑Throughput NGS (Illumina NovaSeq) | Targeted Sanger Sequencing |
| Precision / Sensitivity | 99.9% Diagnostic Sensitivity | ~90% (limited to known hot‑spots) |
| Turnaround Time | 3 – 4 Weeks | 6 – 8 Weeks |
| Coverage | Full gene + flanking regions | Selected exons only |
| Data Interpretation | AI‑augmented variant classification | Manual curation |
Physician Insight & Safety Protocols
“Genetic testing for hereditary neuropathy carries deep personal and familial implications. A positive TFG variant provides a definitive molecular anchor, yet it must always be weighed against the full clinical picture and three‑generation pedigree. A negative result does not exclude all neuropathies; ongoing clinical surveillance remains essential. My role is to guide you through the interpretation with clarity and compassion.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory – Medication and Clinical Management
Results from this genetic test may influence your treatment plan, but you should never adjust or cease any current therapy without first consulting your treating neurologist. Abrupt medication changes can lead to serious clinical deterioration.
Exclusion Criteria & Contraindications
- Informed Consent Capacity: Individuals unable to provide written informed consent due to advanced cognitive impairment, acute psychiatric episodes, or diminished decision‑making capacity are excluded.
- Medical Instability: Patients experiencing acute respiratory distress, ongoing seizure activity, or hemodynamic instability at the time of scheduled collection.
- Age Restrictions: For minors (under 18 years), written consent from a legal guardian is required as per Federal Decree-Law No. 4 of 2016 on Medical Liability.
- Blood Draw Tolerance: Individuals with severe needle phobia or a history of vasovagal syncope that cannot be managed with standard clinical support.
Patient FAQ & Clinical Guidance
1. What exactly does the TFG gene test diagnose?
This NGS test sequences your entire TFG gene to detect mutations causing hereditary motor and sensory neuropathy, Okinawa type (HMSN‑P). It confirms the diagnosis at the DNA level, differentiating it from other Charcot‑Marie‑Tooth subtypes and guiding targeted management.
2. How should I prepare for this genetic test?
You must attend a genetic counselling session to draw a family pedigree and discuss the implications before sample collection. Fasting is not required, but please stay hydrated on the day of your blood draw.
3. What does a positive result mean for my family?
A positive result confirms the diagnosis and indicates an autosomal dominant inheritance pattern, meaning each child has a 50% risk of inheriting the condition. Predictive testing can then be offered to at‑risk relatives for early surveillance.
UAE Regulatory & Data Privacy Adherence
Data Protection & Health Information Governance
Your genetic data is handled in strict compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All sequencing results are encrypted, access‑controlled, and stored on UAE‑based secure servers. No genetic information is shared with third parties without your explicit written consent.
Clinical & Logistical Metadata
| Test Name | TFG Gene Hereditary Motor and Sensory Neuropathy, Okinawa Type Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3 – 4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood (VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection, Daily 8 AM – 11 PM) |
| Methodology Used | High‑Throughput NGS (Illumina NovaSeq) |
| ICD-10-CM Code | G60.0 |
| LOINC Code | 21636-6 |
| DHA Facility License & Laboratory Address | DHA Facility License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians